Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130C Paragraph 1 Sgb V Between Ikk Classic And Astrazeneca Gmbh For Xigduo

IKK classic Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130C Paragraph 1 Sgb V Between Ikk Classic And Astrazeneca Gmbh For Xigduo in Pharmaceuticals. The tender was released on Nov 26, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130C Paragraph 1 Sgb V Between Ikk Classic And Astrazeneca Gmbh For Xigduo

Deadline - login to view

MT reference number - 98402042

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 98402042

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 SGB V between IKK classic and AstraZeneca GmbH for Xigduo (active ingredient Metformin+Dapagliflozin, ATC code: A10BD15)local title:: Abschluss eines n icht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der AstraZeneca GmbH zu XigduoContract Type: : Supplylocal description: : Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der AstraZeneca GmbH zu Xigduo (Wirkstoff Metformin+Dapagliflozin, ATC-Code: A10BD15)Net Budget Euro: : 1.0Net Budget LC: : 1.0 dispatch_date: 2024-11-25 00:00:00 est_amount: 1.0

Mt Ref Id - 98402042

Deadline - Nov 30, -0001

Share

Similar Tenders :